Home-based Exercise for SMI
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06078293 |
Recruitment Status :
Not yet recruiting
First Posted : October 11, 2023
Last Update Posted : October 16, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Serious Mental Illness | Behavioral: Home-based Exercise Program | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 30 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Feasibility Study of Home-based Exercise for Older Veterans With Serious Mental Illness |
Estimated Study Start Date : | August 3, 2026 |
Estimated Primary Completion Date : | November 6, 2028 |
Estimated Study Completion Date : | July 31, 2029 |
Arm | Intervention/treatment |
---|---|
Experimental: Exercise
All participants in this single-arm trial will be in the exercise arm and receive the home-based exercise program.
|
Behavioral: Home-based Exercise Program
12-week home-based exercise program that involves individualized exercise prescription and motivational health coaching calls. |
- Feasibility/Acceptability as measured by eligibility rate [ Time Frame: Through completion of study (an average of 2 years) ]Eligibility rate when screening participants (12% is benchmark)
- Feasibility/Acceptability as measured by number of participants enrolled in the study [ Time Frame: Through completion of study (an average of 2 years) ]Number of participants enrolled in the study (benchmark is n=30)
- Feasibility/Acceptability as measured by exercise session adherence [ Time Frame: End of intervention (12 weeks) ]Percentage of exercise sessions completed out of total number prescribed (60% is benchmark)
- Feasibility/Acceptability as measured by coaching call adherence [ Time Frame: End of intervention (12 weeks) ]Percentage of motivational health coaching calls completed out of total scheduled (60% is benchmark)
- Feasibility/Acceptability as measured by orientation session fidelity [ Time Frame: End of intervention (12 weeks) ]Percentage of administered orientation sessions with a fidelity rating of at least adequate (80% is benchmark)
- Feasibility/Acceptability as measured by coaching call session fidelity [ Time Frame: End of intervention (12 weeks) ]Percentage of administered coaching calls with a fidelity rating of at least adequate (80% is benchmark)
- Feasibility/Acceptability as measured by Client Satisfaction Questionnaire Total Score [ Time Frame: End of intervention (12 weeks) ]Total score on the Client Satisfaction Questionnaire (CSQ-8), which is an 8-item measure with each item scored from 1-4 with higher scores representing greater acceptability of the intervention and the range of total scores spanning 8-32 (24 is benchmark).
- Feasibility/Acceptability as measured by retention [ Time Frame: Through completion of study (an average of 2 years) ]Percentage of participants that completed the endpoint assessment (70% is benchmark)
- Feasibility/Acceptability as measured by assessment duration [ Time Frame: End of intervention (12 weeks) ]Length of the assessment battery in minutes (60 minutes is benchmark)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Veteran enrolled at Providence VAHCS
- age 50 or older
- chart diagnosis of SMI (i.e., schizophrenia, schizoaffective disorder, or bipolar disorder)
- clinically stable defined as no inpatient psychiatric admission in the prior three months and no changes in psychiatric treatment in prior month
- medically safe to participate in exercise defined by no inpatient medical admission in prior three months and sign-off by Veteran's medical provider
Exclusion Criteria:
- diagnosis of Alzheimer's or related dementia
- presence of any medical contraindication for exercise including unstable angina, active proliferative diabetic retinopathy, oxygen dependence, or frank incontinence
- already participating in regular exercise defined as at least 60 minutes/week every week for prior six months or currently enrolled in a VA exercise or health promotion program
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06078293
Contact: Julia W Browne, PhD | (401) 273-7100 ext 15051 | Julia.Browne@va.gov | |
Contact: Melanie Parent, BA | (401) 273-7100 ext 6293 | Melanie.Parent@va.gov |
United States, Rhode Island | |
Providence VA Medical Center, Providence, RI | |
Providence, Rhode Island, United States, 02908-4734 | |
Contact: Julia W Browne, PhD 401-273-7100 ext 15051 Julia.Browne@va.gov | |
Principal Investigator: Julia W Browne, PhD |
Principal Investigator: | Julia W Browne, PhD | Providence VA Medical Center, Providence, RI |
Responsible Party: | VA Office of Research and Development |
ClinicalTrials.gov Identifier: | NCT06078293 |
Other Study ID Numbers: |
E5010-W RX005010 ( Other Grant/Funding Number: VA RRD ) |
First Posted: | October 11, 2023 Key Record Dates |
Last Update Posted: | October 16, 2023 |
Last Verified: | October 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
schizophrenia schizoaffective disorder bipolar disorder |
exercise physical function home-based |
Mental Disorders |